Literature DB >> 21169420

MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells.

Kyounghyun Kim1, Robert Burghardt, Rola Barhoumi, Syng-Ook Lee, Xinyi Liu, Stephen Safe.   

Abstract

Murine double minute clone 2 (MDM2) is a multifunctional protein, which modulates nuclear receptor-mediated transactivation. In this study, we show that MDM2 significantly enhanced estrogen receptor α (ERα) and ERα/specificity protein-mediated transactivation in MCF-7 and ZR-75 breast cancer cells. This was demonstrated by both MDM2 overexpression and knockdown experiments by RNA interference. ERα interacted with wild-type MDM2 and deletion mutants of MDM2 containing amino acids 1-342 (C-terminal deletion) and 134-490 (N-terminal deletion), but not 134-342. In contrast, only wild-type but not mutant MDM2 enhanced ERα-mediated transactivation. Protein-protein interactions in vitro were 17β-estradiol (E(2)) independent, whereas fluorescent resonance energy transfer experiments in living cells showed that E(2) enhanced ERα-MDM2 interactions. Subsequent RNA interference and mammalian two-hybrid experiments suggested that MDM2 did not directly interact with endogenous coactivators such as the steroid receptor coactivators but played a role in enhancing ERα-mediating gene expression and estrogen responsiveness through interactions with ERα.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21169420      PMCID: PMC3069690          DOI: 10.1677/JME-10-0110

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  53 in total

1.  RB regulates the stability and the apoptotic function of p53 via MDM2.

Authors:  J K Hsieh; F S Chan; D J O'Connor; S Mittnacht; S Zhong; X Lu
Journal:  Mol Cell       Date:  1999-02       Impact factor: 17.970

2.  p300/MDM2 complexes participate in MDM2-mediated p53 degradation.

Authors:  S R Grossman; M Perez; A L Kung; M Joseph; C Mansur; Z X Xiao; S Kumar; P M Howley; D M Livingston
Journal:  Mol Cell       Date:  1998-10       Impact factor: 17.970

3.  The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.

Authors:  J J Voegel; M J Heine; M Tini; V Vivat; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

4.  Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions.

Authors:  W Wang; L Dong; B Saville; S Safe
Journal:  Mol Endocrinol       Date:  1999-08

5.  The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter.

Authors:  T Léveillard; B Wasylyk
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

6.  Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer.

Authors:  Kyounghyun Kim; Rola Barhoumi; Robert Burghardt; Stephen Safe
Journal:  Mol Endocrinol       Date:  2005-01-06

7.  Analysis of the degradation function of Mdm2.

Authors:  M H Kubbutat; R L Ludwig; A J Levine; K H Vousden
Journal:  Cell Growth Differ       Date:  1999-02

8.  Regulation of p53 function and stability by phosphorylation.

Authors:  M Ashcroft; M H Kubbutat; K H Vousden
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

9.  DRIP150 coactivation of estrogen receptor alpha in ZR-75 breast cancer cells is independent of LXXLL motifs.

Authors:  Jeongeun Eun Lee; Kyounghyun Kim; James C Sacchettini; Clare V Smith; Stephen Safe
Journal:  J Biol Chem       Date:  2004-12-28       Impact factor: 5.157

10.  Vitamin D-interacting protein 205 (DRIP205) coactivation of estrogen receptor alpha (ERalpha) involves multiple domains of both proteins.

Authors:  Qian Wu; Robert Burghardt; Stephen Safe
Journal:  J Biol Chem       Date:  2004-10-05       Impact factor: 5.157

View more
  15 in total

Review 1.  Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy.

Authors:  Wen Zhou; Joyce M Slingerland
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

2.  Impact of the Mdm2(SNP309-G) allele on a murine model of colorectal cancer.

Authors:  X Zhang; L Pageon; S M Post
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

3.  Subcellular localization of Mdm2 expression and prognosis of breast cancer.

Authors:  Hyung Seok Park; Ji Min Park; Seho Park; Junghoon Cho; Seung Il Kim; Byeong-Woo Park
Journal:  Int J Clin Oncol       Date:  2013-11-29       Impact factor: 3.402

Review 4.  MDM2, MDMX and p53 in oncogenesis and cancer therapy.

Authors:  Mark Wade; Yao-Cheng Li; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2013-01-10       Impact factor: 60.716

5.  Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics.

Authors:  Mattia Lion; Alessandra Bisio; Toma Tebaldi; Veronica De Sanctis; Daniel Menendez; Michael A Resnick; Yari Ciribilli; Alberto Inga
Journal:  Cell Cycle       Date:  2013-03-21       Impact factor: 4.534

6.  BAG2-Mediated Inhibition of CHIP Expression and Overexpression of MDM2 Contribute to the Initiation of Endometriosis by Modulating Estrogen Receptor Status.

Authors:  Li-Juan Chen; Bin Hu; Zhi-Qiang Han; Jian-Hua Zhu; Xu Fan; Xue-Xing Chen; Zi-Ping Li; Hao Zhou
Journal:  Front Cell Dev Biol       Date:  2021-04-27

7.  FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.

Authors:  Ying Liu; Xiang Ao; Zhaojun Jia; Xiao-Yan Bai; Zhaowei Xu; Gaolei Hu; Xiao Jiang; Min Chen; Huijian Wu
Journal:  Sci Rep       Date:  2015-03-05       Impact factor: 4.379

8.  Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.

Authors:  Wendy M Swetzig; Jianmin Wang; Gokul M Das
Journal:  Oncotarget       Date:  2016-03-29

9.  Formal modeling and analysis of ER-α associated Biological Regulatory Network in breast cancer.

Authors:  Samra Khalid; Rumeza Hanif; Samar H K Tareen; Amnah Siddiqa; Zurah Bibi; Jamil Ahmad
Journal:  PeerJ       Date:  2016-10-20       Impact factor: 2.984

10.  Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy.

Authors:  Zhuan Zhou; Joe X Qiao; Amit Shetty; George Wu; Yi Huang; Nancy E Davidson; Yong Wan
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.